 Phoenix Financial Ltd. acquired a new stake in shares of  Cardinal Health, Inc. (NYSE:CAH – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,205 shares of the company’s stock, valued at approximately $203,000.
Phoenix Financial Ltd. acquired a new stake in shares of  Cardinal Health, Inc. (NYSE:CAH – Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 1,205 shares of the company’s stock, valued at approximately $203,000. 
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its stake in shares of Cardinal Health by 28.4% during the first quarter. GAMMA Investing LLC now owns 7,004 shares of the company’s stock valued at $965,000 after acquiring an additional 1,549 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in shares of Cardinal Health by 15.1% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 35,790 shares of the company’s stock valued at $4,931,000 after acquiring an additional 4,693 shares in the last quarter. Oppenheimer & Co. Inc. raised its position in Cardinal Health by 489.1% during the 1st quarter. Oppenheimer & Co. Inc. now owns 13,273 shares of the company’s stock valued at $1,829,000 after purchasing an additional 11,020 shares in the last quarter. Asset Management One Co. Ltd. raised its position in Cardinal Health by 10.6% during the 1st quarter. Asset Management One Co. Ltd. now owns 135,595 shares of the company’s stock valued at $18,681,000 after purchasing an additional 12,960 shares in the last quarter. Finally, Golden State Equity Partners bought a new stake in Cardinal Health during the 1st quarter valued at $433,000. Institutional investors own 87.17% of the company’s stock.
Insider Buying and Selling at Cardinal Health
In related news, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This represents a 44.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Ola M. Snow sold 28,151 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the transaction, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This represents a 64.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 271,676 shares of company stock valued at $40,489,525. Corporate insiders own 0.12% of the company’s stock.
Cardinal Health Stock Performance
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. Cardinal Health’s revenue was up .5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were given a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio is presently 31.63%.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on CAH. UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Evercore ISI decreased their price objective on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Argus set a $189.00 price target on shares of Cardinal Health in a report on Friday, August 22nd. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $166.00.
Check Out Our Latest Analysis on Cardinal Health
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories
- Five stocks we like better than Cardinal Health
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Warner Bros. Bidding War Potential: How High Could WBD Shares Go?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Analysts Eye 30% Upside in Netflix After Q3 Earnings Crash
- What Are Growth Stocks and Investing in Them
- O’Reilly Automotive’s Stock Price Uptrend Will Continue in 2026
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

 
						 
						 
						